1.
Study of 18β glycyrrhetinic acid for the prevention of progression of diabetes induced neuropathy in laboratory animals. Int. J. Pharm. Sci. Drug Res. [Internet]. 2021 Mar. 30 [cited 2025 Dec. 1];13(2):107-19. Available from: https://ijpsdronline.com/index.php/journal/article/view/1595